NeuroBo Pharma (NRBO) - Kapitalisasi pasar

NeuroBo Pharmaceuticals (NRBO) is fighting for market share in the metabolic disorders segment, challenging the influence of industry behemoths. The company is automating bioanalysis using AI and robotics to accelerate drug discovery. The price indicator on the chart recorded a value of 0.02. Risks are being minimized through the development of treatments for obesity and liver pathologies, ensuring the business's financial stability.

NRBO NeuroBo Pharmaceuticals, Inc.: Nilai pasar ing interval 04.07.2022 - 07.12.2024

NRBO (NeuroBo Pharma): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji NeuroBo Pharmaceuticals (NRBO):

Bagan rega NeuroBo Pharmaceuticals, Inc.|NRBO - Konsensus nilai wajar|Kapitalisasi pasar NeuroBo Pharma

Analisis fundamental perusahaan:NRBO (NeuroBo Pharmaceuticals, Inc.)

Sampel barang neurobopharma.com

NeuroBo Pharmaceuticals (NRBO) developments in neuroscience are critically dependent on FDA approval and the influx of R&D capital. An analysis of the issuer's market capitalization allows for the real-time tracking of the total market value of all shares. This metric aggregates the current quote and the total number of securities, reflecting the collective valuation of the business. This chart helps promptly assess investment attractiveness and drawdown risks. The shares are classified as high-risk biotechnological assets.

Pesaing wigati

Nilai pasar Biogen BIIB|Nilai pasar NBIX|Regencell - Kapitalisasi pasar|AXSM: Nilai pasar|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Nilai pasar xenon-pharma.com (XENE)|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|Kapitalisasi pasar PRTA (Prothena Corp)|Kapitalisasi pasar ALEC|ANNX - Nilai pasar|Omeros - Biji pasar|Kapitalisasi pasar Neurogene Therapeutics NGNE|ACIU - Nilai pasar|Nilai pasar VYGR (voyagertherapeutics.com)|Neumora Therapeutics, Inc. (NMRA) - Nilai pasar|Nilai pasar Scilex Holding (SCLX)|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Nilai pasar ACOG|Nilai pasar Cognition Therapeutics, Inc. (CGTX)|IKT - Nilai pasar|Cassava Sciences - Biji pasar|Nilai pasar ASRT|COYA - Nilai pasar|Biji pasar VTGN|OVID: Kapitalisasi pasar|acumenpharm.com - Nilai pasar|CRVO (CervoMed) - Kapitalisasi pasar|Kapitalisasi pasar Alterity Therapeutics Ltd|Nilai pasar Clene Inc. (CLNN)|PEPG (pepgen.com) - Nilai pasar|Nilai pasar Jupiter Neurosciences JUNS|RLMD - Biji pasar|Annovis Bio - Kapitalisasi pasar|GRCE - Kapitalisasi pasar|AIFF: Kapitalisasi pasar|Biji pasar Klotho Neurosciences|NRSN (NeuroSense Therapeutics Ltd) - Kapitalisasi pasar|Nilai pasar revivapharma.com RVPH|Biji pasar MTVA (MetaVia Inc)|Kapitalisasi pasar NeurAxis Inc. (NRXS)|Helius Medical Technologies - Biji pasar|Nilai pasar PASG (Passage Bio Inc.)|Neuphoria - Kapitalisasi pasar|Kapitalisasi pasar minervaneurosciences.com NERV|ATHA: Kapitalisasi pasar|Biji pasar Addex Therapeutics Ltd.|ALZN (Alzamend Neuro Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Cyclerion|Nilai pasar Protagenic Therapeutics (PTIX)|Nilai pasar KTTA (pasitheaclinics.com)|Nilai pasar Cortigent CRGT|Kapitalisasi pasar Avenue Therapeutics Inc. (ATXI)|BCLI - Nilai pasar|CARA (Cara Therapeutics Inc) - Kapitalisasi pasar|Chromocell Therapeutics (CHRO) - Nilai pasar|Eliem Therapeutics Inc. - Nilai pasar|ITCI (Intra-Cellular Therapies Inc.) - Kapitalisasi pasar|Nilai pasar LBPH|Nilai pasar Marinus (MRNS)|NKGN - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|SNPX: Kapitalisasi pasar|Trevena - Kapitalisasi pasar|Nilai pasar Vigil Neuroscience|WENA (Anew Medical, Inc.) - Biji pasar|Cerevel Corp (CERE) - Kapitalisasi pasar